Tag Archives: noncaloric sweeteners

A New Artificial Sweetener: Advantame

Lumps of Diabetes

Sugar or advantame?

The U.S. Food and Drug Administration this last spring approved a new artificial sweetener called advantame. The press release calls it a high-intensity sweetener, which is a new term for me. Advantame joins five other artificial sweeteners:  saccharin (e.g., Sweet’N Low), aspartame (Equal and others), acesulfame potassium (Sweet One and others), sucralose (Splenda), and neotame (Newtame).

From the FDA:

High-intensity sweeteners, such as advantame, may be used in place of sugar for a number of reasons, including that they do not contribute calories or only contribute a few calories to the diet. High-intensity sweeteners also generally will not raise blood sugar levels.

Advantame is a free-flowing, water soluble, white crystalline powder that is stable even at higher temperatures, and can be used as a tabletop sweetener as well as in cooking applications. Advantame has been approved for use as a general-purpose sweetener and flavor enhancer and can be used in baked goods, non-alcoholic beverages (including soft drinks), chewing gum, confections and frostings, frozen desserts, gelatins and puddings, jams and jellies, processed fruits and fruit juices, toppings, and syrups.

I haven’t seen it in stores yet.

Steve Parker, M.D.

3 Comments

Filed under Sugar Substitutes

AHA and ADA Position Paper On Non-Nutritive Sweeteners

The American Heart Association and American Diabetes Association just published a review paper on nonnutritive sweeteners, also known as low-calorie sweeteners, artificial sweeteners, noncaloric sweeteners, and intense sweeteners.  I quote from the conclusion section:

At this time, there are insufficient data to determine conclusively whether the use of NNS to displace caloric sweeteners in beverages and foods reduces added sugars or carbohydrate intakes, or benefits appetite, energy balance, body weight, or cardiometabolic risk factors.

With regard to nonnutritive sweeteners and glycemic response [in diabetics], 4 randomized trials that varied from 1 to 16 weeks in duration found no significant difference between the effects of nonnutritive sweeteners and various comparisons (sucrose, starch, or placebo) on standard measures of glycemic response (i.e., plasma glucose and insulin, HbA1c, C-peptide) and, in general, did not detect clinically relevant effects.

You’re welcome to read the entire document.

-Steve

3 Comments

Filed under Sugar Substitutes